bg
R

Rezolute (RZLT)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Rezolute (RZLT)

Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of conge... Read more

  • USD5.01
  • USD5.04
  • USD4.83
  • USD6.19
  • 12.40%
  • --
  • 1.23M
  • 418M
  • 2.22
  • 20.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.